SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001193125-17-167447
Filing Date
2017-05-11
Accepted
2017-05-11 17:12:29
Documents
8
Period of Report
2017-05-11

Document Format Files

Seq Description Document Type Size
1 PREM14A d390656dprem14a.htm PREM14A 1836419
2 GRAPHIC g390656g05v32.jpg GRAPHIC 26493
3 GRAPHIC g390656g23c52.jpg GRAPHIC 19620
4 GRAPHIC g390656g28c95.jpg GRAPHIC 23655
5 GRAPHIC g390656g29z80.jpg GRAPHIC 23827
6 GRAPHIC g390656g49x28.jpg GRAPHIC 40015
7 GRAPHIC g390656g67s41.jpg GRAPHIC 22084
8 GRAPHIC g390656img1.jpg GRAPHIC 16709
  Complete submission text file 0001193125-17-167447.txt   2075667
Mailing Address UNIT 5, SRAGH TECHNOLOGY PARK RAHAN ROAD TULLAMORE , CO. OFFALY L2 R35 FR98
Business Address UNIT 5, SRAGH TECHNOLOGY PARK RAHAN ROAD TULLAMORE , CO. OFFALY L2 R35 FR98 353 1 215 8100
Nexvet Biopharma plc (Filer) CIK: 0001618561 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 0630
Type: PREM14A | Act: 34 | File No.: 001-36828 | Film No.: 17835399
SIC: 2834 Pharmaceutical Preparations